Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the launch of Extendryl(R) PEM and Extendryl(R) GCP.

Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the FDA approval of Liquadd(TM) (dextroamphetamine sulfate) Oral Solution 5 mg/5 mL indicated for the treatment of Attention Deficit Disorder with Hyperactivity (ADHD).

Auriga Laboratories, Inc. (OTCBB: ARGA), a special

Auriga Laboratories, Inc. (OTCBB:ARGA), a specialt

Auriga Laboratories, Inc. (OTCBB:ARGA), a special